Related Experiment Video

Updated: Apr 26, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K

[Regulation of bone metastasis by microRNAs]

Shingo Sato1, Shu Takeda

  • 1Department of Physiology and Cell Biology, Tokyo Medical and Dental University Graduate School and Faculty of Medicine, Japan.

Clinical Calcium
|July 29, 2014
PubMed

Insights

microRNAs (miRNAs) are key regulators in cancer progression and bone metastasis. Understanding their role in metastatic bone disease can lead to new diagnostic and therapeutic strategies for advanced cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Context:

  • Bone metastasis is a frequent and severe complication in advanced cancer patients.
  • It leads to pain, fractures, and spinal cord compression, significantly impairing quality of life.
  • Identifying molecular drivers of bone metastasis is crucial for developing effective treatments.

Purpose:

  • To explore the role of microRNAs (miRNAs) in the initiation and progression of bone metastasis.
  • To highlight the significance of miRNAs in regulating the development of metastatic bone disease.
  • To emphasize the potential of miRNAs as therapeutic targets for bone metastasis.

Summary:

  • MicroRNAs (miRNAs) are increasingly recognized for their critical roles in cancer development and progression.
  • Recent research highlights the importance of miRNAs in the specific context of bone metastasis.
  • Further investigation into miRNA functions in metastatic bone disease is warranted.

Impact:

  • Unraveling miRNA mechanisms in bone metastasis can pave the way for novel diagnostic biomarkers.
  • This knowledge can facilitate the development of innovative therapeutic strategies targeting bone metastasis.
  • Ultimately, it may improve outcomes for cancer patients experiencing bone metastases.

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.4K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
MicroRNAs01:22

MicroRNAs

9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K